Inventor · disambiguated record
Robert Hugh Bradbury
Also filed as: BRADBURY ROBERT H · BRADBURY ROBERT HUGH
40 granted patents·24 pending applications·1,054 citations·filing 1989–2022
98Inventor score
Top patents by PatentIndex Score
64 records- 0195US6838464B22,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineaoplastic agentsASTRAZENECA AB·Filed 2001·Granted Jan 4, 2005·183 cites·14 claims
- 0295US6710052B2Pyrimidine compoundsASTRAZENECA·Filed 2001·Granted Mar 23, 2004·106 cites·14 claims
- 0395US6593326B12,4-diamino pyrimidine compounds having anti-cell proliferative activityASTRAZENECA AB·Filed 1999·Granted Jul 15, 2003·317 cites·13 claims
- 0492US6649608B22,4-di(hetero-)arylamino (oxy)-5-substituted pyrimidines as antineoplastic agentsASTRAZENECA AB·Filed 2001·Granted Nov 18, 2003·68 cites·15 claims
- 0590US7148230B2Quinazoline derivativesASTRAZENECA AB·Filed 2004·Granted Dec 12, 2006·42 cites·5 claims
- 0689US7067522B22,4,DI (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agentsASTRAZENECA AB·Filed 2004·Granted Jun 27, 2006·40 cites·15 claims
- 0786US9944650B2[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseasesASTRAZENECA AB·Filed 2015·Granted Apr 17, 2018·5 cites·8 claims
- 0883US10766905B2[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseasesASTRAZENECA AB·Filed 2019·Granted Sep 8, 2020·1 cites·8 claims
- 0983US10407432B2[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseasesASTRAZENECA AB·Filed 2018·Granted Sep 10, 2019·3 cites·8 claims
- 1082US6083951AAryl-substituted pyrimidine sulphonamide compounds as endothelin antagonistsZENECA LTD·Filed 1998·Granted Jul 4, 2000·50 cites·13 claims
- 1180US9155727B2Chemical compoundsASTRAZENECA AB·Filed 2014·Granted Oct 13, 2015·5 cites·11 claims
- 1279US8003649B2Bicyclic derivatives for use in the treatment of androgen receptor associated conditions-155ASTRAZENECA AB·Filed 2008·Granted Aug 23, 2011·4 cites·15 claims
- 1375US8258140B2Chemical compounds—643BRADBURY ROBERT HUGH·Filed 2010·Granted Sep 4, 2012·8 cites·8 claims
- 1472US5866568AHeterocyclic compoundsZENECA LTD·Filed 1996·Granted Feb 2, 1999·23 cites·8 claims
- 1571US6258817B1Substituted pyrazin-2-yl-sulphonamide (-3-pyridyl) compounds and uses thereofZENECA LTD·Filed 2000·Granted Jul 10, 2001·4 cites·8 claims
- 1670US8399667B24-anilino quinazoline derivatives as antiproliferative agentsBRADBURY ROBERT HUGH·Filed 2010·Granted Mar 19, 2013·1 cites·11 claims
- 1770US7625908B2Quinazoline derivativesASTRAZENECA AB·Filed 2004·Granted Dec 1, 2009·4 cites·21 claims
- 1870US2023035133A1[1,2,4]Triazolo[4,3-B]Pyridazines For Use in the Treatment of Proliferative DiseasesASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 1969US5861401AN-heterocyclyl sulphonamide derivatives and their use as endothelin antagonistsZENECA LTD·Filed 1995·Granted Jan 19, 1999·24 cites·18 claims
- 2069US5387592ASubstituted benzoxazole, benzthiazole, and benzimidazole derivatives as angiotensin II antagonistsICI PLC·Filed 1992·Granted Feb 7, 1995·23 cites·10 claims
- 2169US5236937APyridinyl compounds which are useful as angiotensin ii antagonistsICI PLC·Filed 1992·Granted Aug 17, 1993·25 cites·11 claims
- 2268US6060475ASubstituted pyrazin-2-yl-sulphonamide-(3-pyridyl) compounds and uses thereofZENECA LTD·Filed 1998·Granted May 9, 2000·21 cites·11 claims
- 2366US11407755B2[1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative diseasesASTRAZENECA AB·Filed 2020·Granted Aug 9, 2022·0 cites·15 claims
- 2465US2008269487A14-anilino quinazoline derivatives as antiproliferative agentsASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2564US5641793APyridine compounds which have useful pharmaceutical activityZENECA LTD·Filed 1995·Granted Jun 24, 1997·22 cites·10 claims
- 2663US5091425A5-(heterocyclylalkanoyl)amino-4-hydroxypentanamidesICI PLC·Filed 1989·Granted Feb 25, 1992·6 cites·12 claims
- 2761US5668137AN-heterocyclic sulfonamides having endothelin receptor activityZENECA LTD·Filed 1996·Granted Sep 16, 1997·24 cites·9 claims
- 2858US2013005727A1Quinazoline derivativesASTRAZENECA AB·Filed 2012·Application pending·0 cites
- 2957US10130617B2Chemical compoundsASTRAZENECA AB·Filed 2017·Granted Nov 20, 2018·0 cites·13 claims
- 3057US2007088044A1Quinazoline derivatives as antitumor agentsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 3156US5130318AAngiotensin ii antagonizers which are condensed pyridine derivativesICI PLC·Filed 1991·Granted Jul 14, 1992·12 cites·11 claims
- 3256US2019038607A1Chemical compoundsASTRAZENECA AB·Filed 2018·Application pending·0 cites
- 3355US2005215574A14-anilino quinazoline derivatives as antiproliferative agentsBRADBURY ROBERT H·Filed 2003·Application pending·0 cites
- 3454US9616050B2Chemical compoundsASTRAZENECA AB·Filed 2015·Granted Apr 11, 2017·0 cites·8 claims
- 3552US5126344ADiazine derivatives and pharmaceutical useICI PLC·Filed 1990·Granted Jun 30, 1992·11 cites·13 claims
- 3652US5049558ACephalosporin derivativesICI PLC·Filed 1989·Granted Sep 17, 1991·6 cites·20 claims
- 3752US2007082921A1Quinazoline derivatives as antitumor agentsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 3848US2005043336A1Quinazoline derivatives as antitumor agentsFiled 2002·Application pending·0 cites
- 3948US2007015743A1Quinazoline derivatives as antitumor agentsBRADBURY ROBERT H·Filed 2004·Application pending·0 cites
- 4048US2007032508A1Quinazoline derivatives as tyrosine kinase inhibitorsBRADBURY ROBERT H·Filed 2004·Application pending·0 cites
- 4147US5254679ACephalosporin intermediatesICI PLC·Filed 1991·Granted Oct 19, 1993·3 cites·17 claims
- 4247US2005054662A1Quinazoline derivatives as antitumor agentsFiled 2002·Application pending·0 cites
- 4347US2007149546A14-Anilino-quinazoline derivatives as antiproliferative agentsBRADBURY ROBERT H·Filed 2004·Application pending·0 cites
- 4446US5281613AHeterocyclic compoundsICI PLC·Filed 1992·Granted Jan 25, 1994·6 cites·9 claims
- 4546US2009023759A1Quinazoline Derivatives as Inhibitors of EGF and/or erbB2 Receptor Tyrosine KinaseBRADBURY ROBERT HUGH·Filed 2006·Application pending·0 cites
- 4645US5236936APyridine compounds which are useful as angiotensin ii receptor antagonistsICI PLC·Filed 1992·Granted Aug 17, 1993·2 cites·9 claims
- 4745US2009137615A1Indazolylamino quinazoline derivatives as antitumour agentsBRADBURY ROBERT HUGH·Filed 2006·Application pending·0 cites
- 4845US2007099943A1Quinazoline derivativesASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 4945US2007232607A1Quinazoline Derivatives as Erbb Receptor Tyrosine kinasesBRADBURY ROBERT H·Filed 2005·Application pending·0 cites
- 5045US2012329795A1Quinazoline derivativesHENNEQUIN LAURENT FRANCOIS ANDRE·Filed 2012·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Robert Hugh Bradbury files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →